Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01368640
Other study ID # BCA-01
Secondary ID
Status Completed
Phase N/A
First received April 15, 2011
Last updated October 2, 2012
Start date April 2011
Est. completion date August 2012

Study information

Verified date October 2012
Source Seca GmbH & Co. Kg.
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

Aim of the study is to develop prediction equations for calculating FFM, TBW, ECW and SMM based on the gold standard reference methods ADP, DXA, MRI, D2O and NaBr on the one hand and measurement data of the BIA devices on the other hand. The equations are necessary to use the device as a Body Composition Analyzer with an acceptable accuracy level for clinical practice.


Recruitment information / eligibility

Status Completed
Enrollment 153
Est. completion date August 2012
Est. primary completion date September 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

The study will cover 130 healthy adults. 65 men and 65 women in an age range of 18 to 65 years with a BMI of 18.5 to 35 kg/m2 are planned to be recruited.

Exclusion Criteria:

- acute and chronic diseases

- regular intake of medications (except for contraceptives)

- amputation of limbs

- electrical implant as cardiac pacemaker

- insulin pumps

- artificial joints

- metallic implants (except tooth implants)

- claustrophobia

- pregnancy or breastfeeding period

- probands who cannot provide an ICF by themselves

- probands who might be dependent from the sponsor or the inv. site

- current alcohol abuse

- frequent hypersensitivity reactions/allergies determ. anamnestically

- body weight of more than 150 kg

- extensive tattoos at arms or legs

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms

  • Bioelectrical Impedance Measurement of Healthy Adults

Locations

Country Name City State
Germany Institute of Human Nutrition and Food Science Kiel

Sponsors (1)

Lead Sponsor Collaborator
Seca GmbH & Co. Kg.

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bioelectrical Impedance of 5 and 50 kHz for one body side 15 minutes No
Primary Bioelectrical Impedance of 50 kHz for all 4 extremities 15 minutes No
Secondary Bioelectrical Impedance of 1, 1.5, 2, 3, 7.5, 10, 15, 20, 30, 75, 100, 150, 200, 300, 500, 750 and 1,000 kHz The measurement is planned to be done for all body segments: right arm, left arm, right leg, left leg, trunk, right body side and left body side. In total resistance and reactance at 19 frequencies for 7 body segments are planned to be measured. 15 minutes No
Secondary Generation of prediction equations for Sceletal Muscle Mass based on MRI 1 hour No
Secondary Bioelectrical Impedance in sitting, lying and standing 15 minutes No
Secondary Precision Study The precision study pursues three targets:
Repeatability (variability across successive measurements within a short time period taken by the same operator and the same device; device is repositioned between successive measurements).
Between-operator precision (variability across measurements taken by the same device, but different operators).
Between-device precision (variability across measurements taken by the same operator, but different devices).
15 min No
See also
  Status Clinical Trial Phase
Completed NCT04030416 - Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515
Completed NCT01471938 - Application and Adaption of Device Specific Body Composition Formulas to Various Ethnic Groups N/A
Completed NCT03779932 - Generation of Prediction Equations to Analyze Body Composition of Obese Adults Based on BIA